tradingkey.logo

NeuroOne Medical Technologies Corp

NMTC
查看详细走势图
0.780USD
+0.045+6.16%
收盘 02/06, 16:00美东报价延迟15分钟
39.02M总市值
亏损市盈率 TTM

NeuroOne Medical Technologies Corp

0.780
+0.045+6.16%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+6.16%

5天

-11.83%

1月

-13.28%

6月

+2.67%

今年开始到现在

+2.94%

1年

-27.07%

查看详细走势图

操作建议

NeuroOne Medical Technologies Corp当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名79/205位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价2.30。中期看,股价处于上升通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

NeuroOne Medical Technologies Corp评分

相关信息

行业排名
79 / 205
全市场排名
214 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

NeuroOne Medical Technologies Corp亮点

亮点风险
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
业绩高增长
公司营业收入稳步增长,连续3年增长250.82%
业绩增长期
公司处于发展阶段,最新年度总收入12.10M美元
估值低估
公司最新PE估值-8.69,处于3年历史低位
机构减仓
最新机构持股16.80M股,环比减少3.74%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值692.60K
活跃度增加
近期活跃度增加,过去20天平均换手率0.35

分析师目标

根据 2 位分析师
强力买入
评级
2.300
目标均价
+186.71%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

NeuroOne Medical Technologies Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

NeuroOne Medical Technologies Corp简介

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
公司代码NMTC
公司NeuroOne Medical Technologies Corp
CEORosa (David A)
网址https://nmtc1.com/
KeyAI